Akademiska Sjukhuset (Uppsala University hospital)
Uppsala, 75185, Sweden
NCT Number: NCT04083547
This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Uppsala, 75185, Sweden
CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Clinical routine. Disease recurrence and overall survival will be the endpoint used.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
New method of circulating tumour cell detection and capture.
Time frame: 2 year.
Prediction of survival and recurrence according to the occurrence of CTCs.
Uppsala University
Other
Cirkulerande Tumörceller Hos Patienter Med Bukhinnespridda tumörer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04696744
Carcinoma, Carcinoma, Squamous Cell
Lyon, France
View Trial DetailsNCT03700541
Circulating Tumor Cell, Colonic Diseases
Zlin, South Moravian, Czechia
View Trial DetailsNCT03700411
Circulating Tumor Cell, Colonic Diseases
Zlin, South Moravian, Czechia
View Trial DetailsNCT05619562
Bronchial Neoplasms, Carcinoma, Bronchogenic
Olomouc, Česká Republika, Czechia
View Trial Details